CBG
called the "mother of cannabinoids" because its acid form, CBGA, is a poland telegram precursor to many other cannabinoids. It is found in smaller quantities than CBD and THC, but it is gaining acceptance as a treatment for certain health conditions.
CBG may have anti-inflammatory, neuroprotective, and antimicrobial properties. This cannabinoid is also being studied for its potential therapeutic effects on glaucoma, inflammatory bowel disease, and certain types of cancer.
CBG can lower intraocular pressure, fight inflammation, and act as an antioxidant. It also has potential benefits for anxiety, brain protection, skin health, and appetite stimulation.
CBGA
Research into the potential therapeutic effects of CBGA itself is still in its early stages, but it is believed to have anti-inflammatory and neuroprotective properties, among other properties. As scientists continue to explore the various compounds present in cannabis, including CBGA, they may discover more about its potential benefits and applications.
A study from the National Institutes of Health found that CBGA could protect the kidneys of mice from damage caused by different conditions. CBGA prevented kidney inflammation and decreased urine output in mice treated with cisplatin, a chemotherapy drug known to damage the kidneys. CBGA use in the study also prevented weight loss and reduced kidney scarring. These findings from the NIH suggest that CBGA and CBD may hold promise for kidney health.